From: The impact of dementia on drug costs in older people: results from the SNAC study
Non-dementia | Dementia | p-value | |
---|---|---|---|
n= 3,783 | n=319 | ||
Gender, n (%) | |||
Men | 1,462 (38.6) | 63 (19.7) | <0.001 |
Women | 2,321 (61.4) | 256 (80.3) | < 0.001 |
Age groups, n (%) | |||
60-69 | 1,555 (41.1) | 4 (1.3) | < 0.001 |
70-79 | 1,085 (28.7) | 40 (12.5) | < 0.001 |
80-89 | 763 (20.2) | 106 (33.2) | < 0.001 |
≥90 | 380 (10.0) | 169 (53.0) | < 0.001 |
Residential setting, n (%) | |||
Community-dwelling | 3,699 (97.8) | 124 (38.9) | < 0.001 |
Institution | 84 (2.2) | 195 (61.1) | < 0.001 |
Educationb, n (%) | |||
Elementary | 941 (25.1) | 156 (50.8) | < 0.001 |
Additional | 2,823 (74.9) | 153 (49.2) | < 0.001 |
Mean number of drugs | 3.48 | 5.42 | < 0.001 |